ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $386,000 | -44.8% | 94,141 | -51.9% | 0.00% | – |
| Q4 2021 | $699,000 | +33.9% | 195,823 | +36.4% | 0.00% | – |
| Q3 2021 | $522,000 | -15.3% | 143,610 | +1.7% | 0.00% | – |
| Q2 2021 | $616,000 | -34.8% | 141,214 | -38.6% | 0.00% | – |
| Q1 2021 | $945,000 | +16.2% | 229,858 | +12.8% | 0.00% | – |
| Q4 2020 | $813,000 | +40.9% | 203,766 | -4.6% | 0.00% | – |
| Q3 2020 | $577,000 | +28.2% | 213,534 | +30.5% | 0.00% | – |
| Q2 2020 | $450,000 | +111.3% | 163,576 | +80.8% | 0.00% | – |
| Q1 2020 | $213,000 | -61.9% | 90,483 | -23.9% | 0.00% | – |
| Q4 2019 | $559,000 | -19.1% | 118,862 | -42.5% | 0.00% | – |
| Q3 2019 | $691,000 | +73.6% | 206,548 | +70.8% | 0.00% | – |
| Q2 2019 | $398,000 | +53.7% | 120,944 | +41.7% | 0.00% | – |
| Q1 2019 | $259,000 | -6.2% | 85,377 | -15.9% | 0.00% | – |
| Q4 2018 | $276,000 | +71.4% | 101,544 | +112.6% | 0.00% | – |
| Q3 2018 | $161,000 | +43.8% | 47,772 | +10.1% | 0.00% | – |
| Q2 2018 | $112,000 | -6.7% | 43,381 | -20.5% | 0.00% | – |
| Q1 2018 | $120,000 | +106.9% | 54,557 | +84.2% | 0.00% | – |
| Q4 2017 | $58,000 | +13.7% | 29,614 | +87.7% | 0.00% | – |
| Q3 2017 | $51,000 | +112.5% | 15,778 | +112.5% | 0.00% | – |
| Q2 2017 | $24,000 | +41.2% | 7,424 | +21.0% | 0.00% | – |
| Q1 2017 | $17,000 | +41.7% | 6,135 | +22.7% | 0.00% | – |
| Q4 2016 | $12,000 | +50.0% | 5,002 | -3.7% | 0.00% | – |
| Q3 2016 | $8,000 | -85.2% | 5,193 | -89.9% | 0.00% | – |
| Q2 2016 | $54,000 | +2600.0% | 51,390 | +1955.6% | 0.00% | – |
| Q1 2016 | $2,000 | -71.4% | 2,500 | -60.0% | 0.00% | – |
| Q4 2015 | $7,000 | 0.0% | 6,247 | +44.5% | 0.00% | – |
| Q3 2015 | $7,000 | -97.1% | 4,322 | -96.3% | 0.00% | – |
| Q2 2015 | $242,000 | +2925.0% | 116,652 | +3707.2% | 0.00% | – |
| Q1 2015 | $8,000 | -88.7% | 3,064 | -88.9% | 0.00% | – |
| Q4 2014 | $71,000 | -66.7% | 27,510 | -76.3% | 0.00% | – |
| Q3 2014 | $213,000 | +475.7% | 116,107 | +747.5% | 0.00% | – |
| Q2 2014 | $37,000 | -75.5% | 13,700 | -68.2% | 0.00% | – |
| Q1 2014 | $151,000 | +694.7% | 43,082 | +929.4% | 0.00% | – |
| Q4 2013 | $19,000 | -79.8% | 4,185 | -81.9% | 0.00% | – |
| Q3 2013 | $94,000 | -25.4% | 23,058 | -24.0% | 0.00% | – |
| Q2 2013 | $126,000 | – | 30,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |